RecruitingNCT07707609

Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

EVALUATION OF THE RELATIONSHIP BETWEEN NEURAL SENSITISATION AND NEUROPSYCHOLOGICAL ALTERATIONS IN PATIENTS WITH PAINFUL CHRONIC PANCREATITIS


Sponsor

Asian Institute of Gastroenterology, India

Enrollment

200 participants

Start Date

Jan 6, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic pancreatitis (CP) is a progressive inflammatory disease in which chronic abdominal pain affects up to 80% of patients and remains difficult to manage despite treatment of pancreatic pathology. Increasing evidence suggests that persistent pain is not solely driven by peripheral pancreatic abnormalities but also by central sensitization, involving maladaptive changes in central nervous system pain-processing pathways. While altered brain connectivity and neurochemical changes have been demonstrated in other chronic pain disorders, these mechanisms remain poorly characterized in CP. This study aims to integrate clinical phenotyping with blood-based metabolite profiling and advanced neuroimaging, including resting-state functional MRI and magnetic resonance spectroscopy, to investigate the relationship between central sensitization, brain dysfunction, and neuropsychological alterations. The findings may identify objective neurobiological markers of pain and facilitate the development of mechanism-based, personalized treatment strategies for patients with chronic pancreatitis.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood-Based Metabolite Profiling, Comprehensive Neuropsychological Assessment, and others for people with chronic pancreatitis and pain management. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTComprehensive Neuropsychological Assessment

A comprehensive set of clinical and neurological tests to be performed on all participants. This includes validated mental state and sleep evaluations (HADS, PSQI), quality-of-life assessments (EORTC QLQ-C30 + PAN28),and quantitative sensory testing (P-QST)

DIAGNOSTIC_TESTResting-State Functional MRI (fMRI)

An advanced neuroimaging scan performed on all participants to assess resting-state functional connectivity within key pain-processing networks.

DIAGNOSTIC_TESTMagnetic Resonance Spectroscopy (MRS)

A neuroimaging technique performed on all participants to quantify brain metabolites in key brain regions.

DIAGNOSTIC_TESTBlood-Based Metabolite Profiling

Blood samples will be collected from all participants to quantify metabolomic signatures and to identify potential correlates with pain phenotypes in chronic pancreatitis.


Locations(1)

Asian Institute of Gastroenterology

Hyderabad, Telangana, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07707609


Related Trials